CURE241220C94000
- 0.00
- 0.000.00%
Direxion Daily Healthcare Bull 3X Shares Newsroom
AbbVie Analyst Ratings
Novo Nordisk Said to Have Contracted Ypsomed to Make Next Gen Obesity Drug's Pens
Zevra Niemann-Pick Disease Type C Drug Miplyffa Now Available
Johnson & Johnson Announces Health Canada Authorizes CARVYKTI For Patients With Relapsed Or Refractory Multiple Myeloma Who Have Received 1-3 Prior Lines Of Therapy, Including A Proteasome Inhibitor And An Immunomodulatory Agent, And Who Are...
Shares Of Hims & Hers Health See Volume; Traders Circulate Court Filing Regarding Shortage Of Lilly's Tirzepatide Shortage, Parties Agree To Maintain Stay As Ordered By Court In October 2024, With Joint Status Report Due By December 19, 2024, Or...
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Hims & Hers Closes up 10% as Lilly Tirzepatide Compounding Dispute Resolution Delayed
Optimism Over Global Healthcare Sector Rises: Jefferies
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Citi Research's U.S. Equity Strategy Large-Cap Recommendation List
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Pyxis Stock Craters 46% Amid Phase 1 Data, William Blair Downgrade
Price Over Earnings Overview: Johnson & Johnson
Pyxis Oncology Plummets 38% on Preliminary Phase 1 Data for Cancer Asset
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
Eli Lilly in Pact With Chinese Biotech for Novel Weight Loss Therapy
Goldman's Hedge Fund VIP List: AMZN, VST, CRM, BABA, and More
Unpacking the Latest Options Trading Trends in AbbVie